Skip to Main Content

Author Details

Barry Woodhams
Haemacon Ltd
1976
68
21
PMIDPaper TitleJournal TitlePublished Year
32224381Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease.Thromb Res2020
30602199Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.Thromb Haemost2019
31231949Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity.J Thromb Haemost2019
29356352VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia.Int J Lab Hematol2018
27522621Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.Clin Chem Lab Med2017
28669410Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).Thromb Res2017
26951189Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery.Intern Emerg Med2016
26354831Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.Thromb Haemost2016
26967388Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.Oncotarget2016
27061056Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.J Thromb Haemost2016
25318550Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.Thromb Haemost2015
26067611Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women.Scand J Clin Lab Invest2015
26037284Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia.Thromb Res2015
25963480Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.Ann Surg Oncol2015
23504244Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?Intern Emerg Med2014
24816676Circulating microparticles in carriers of prothrombin G20210A mutation.Thromb Haemost2014
24696689Procoagulant phospholipids and tissue factor activity in cerebrospinal fluid from patients with intracerebral haemorrhage.Adv Hematol2014
24298933Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?J Thromb Haemost2014
24383845Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics.Br J Haematol2014
24418946Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity.Blood Coagul Fibrinolysis2014
24009132Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.Am J Hematol2014
23096108Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.Clin Chem Lab Med2013
24028756Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism.Thromb Res2013
23790234The evaluation of two automated soluble fibrin assays for use in the routine hospital laboratory.Int J Lab Hematol2013
23446552Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism.Thromb Haemost2013
23488878Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia.J Matern Fetal Neonatal Med2013
23256818Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.J Thromb Haemost2013
22958499Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.Int J Lab Hematol2013
21707936On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.Int J Lab Hematol2012
22967748Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.J Neurol Sci2012
22836806Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis.Thromb Haemost2012
22535498The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.Thromb Haemost2012
22444156Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis.Thromb Res2012
22551976Decreased procoagulant phospholipids in patients treated by vitamin K antagonists.Thromb Res2012
21880353Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: the cause of hypercoagulability?Thromb Res2012
21925715Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.Thromb Res2012
20874780An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies.J Thromb Haemost2011
21569219Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass.Int J Lab Hematol2011
21708400Factor VIIa-antithrombin complexes in children with ischemic stroke.Thromb Res2011
20431847Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis.Thromb Haemost2010
19593117Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids.Blood Coagul Fibrinolysis2009
15921724Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.Thromb Res2006
16449315Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.Ann Rheum Dis2006
16680742Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.Am J Hematol2006
15116250Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk.Thromb Haemost2004
11781234Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.Blood2002
11505084The clinical relevance of the citrate effect on International Normalized Ratio determinations depends on the reagent and instrument combination used.Blood Coagul Fibrinolysis2001
11460005Stability of coagulation proteins in frozen plasma.Blood Coagul Fibrinolysis2001
10695768A study of the variability seen in the international normalized ratio obtained using different sensitivity thromboplastin reagents on different instrument types.Blood Coagul Fibrinolysis1999
10456477Detection of PF4-heparin auto-antibodies by ELISA.Thromb Haemost1999
  • 1 - 50 of 68

Recommended Authors

Kimberly A Thomas
Washington University in St. Louis School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Christopher A Tormey
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 0
Jay S Raval
University of New Mexico
Career Start Year 2006
Number of shared co-authors 1
Benjamin F Tillman
Vanderbilt University Medical Center
Career Start Year 2006
Number of shared co-authors 1
Trung C Nguyen
Texas Children's Hospital Baylor College of Medicine
Career Start Year 2001
Number of shared co-authors 2
Thorsten Haas
Munich Municipal Hospital Group
Career Start Year 1999
Number of shared co-authors 0
Nicole D Zantek
University of Minnesota
Career Start Year 1999
Number of shared co-authors 0
Ian J Welsby
Duke University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Andrew Eisenberger
NewYork-Presbyterian/Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
Paul Monagle
Kids Cancer Centre, Sydney Children's Hospital
Career Start Year 1995
Number of shared co-authors 0
Achim Obergfell
Novartis Pharma
Career Start Year 1995
Number of shared co-authors 2
Thomas J Raife
University of Wisconsin School of Medicine and Public Health
Career Start Year 1994
Number of shared co-authors 0
Marc Zumberg
University of Florida
Career Start Year 1993
Number of shared co-authors 0
Jeffrey L Winters
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Bruce S Sachais
Clinical Services
Career Start Year 1991
Number of shared co-authors 0
Thomas G DeLoughery
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 0
Claudia S Cohn
University of Minnesota
Career Start Year 1990
Number of shared co-authors 1
Jaroslav G Vostal
Center for Biologics Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
Andrew D Mumford
University of Bristol
Career Start Year 1989
Number of shared co-authors 0
John A Heit
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 0
Robert I Parker
Stony Brook Renaissances School of Medicine, Stony Brook University
Career Start Year 1984
Number of shared co-authors 0
Henry M Rinder
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Willem H Ouwehand
University of Cambridge
Career Start Year 1984
Number of shared co-authors 0
Peter M George
University of Otago
Career Start Year 1983
Number of shared co-authors 0
Thomas L Ortel
Duke University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Jerrold H Levy
Duke University Hospital, Duke University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Steven A Krilis
University of NSW
Career Start Year 1979
Number of shared co-authors 0
Paul M Ness
Johns Hopkins University
Career Start Year 1974
Number of shared co-authors 0
Eric F Grabowski
Massachusetts General Hospital
Career Start Year 1970
Number of shared co-authors 0
David Ginsburg
University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Patrick Van Dreden
Institut Universitaire de Cancerologie (IUC), Sorbonne Universite
Co-authored papers 9
Mariette Adam
Co-authored papers 5
Vladimir Y Bogdanov
University of Cincinnati College of Medicine
Co-authored papers 3
Dusten Unruh
Feinberg School of Medicine, Northwestern University
Co-authored papers 3
Francesco Bernardi
Co-authored papers 3
Nicola Martinelli
Co-authored papers 3
Oliviero Olivieri
Co-authored papers 3
Anders Hamsten
Co-authored papers 2
Syed A Ahmad
University of Cincinnati College of Medicine
Co-authored papers 2
Angela Silveira
Co-authored papers 2
Domenico Girelli
Co-authored papers 2
Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 1
Christopher J Lindsell
Duke University
Co-authored papers 1
Farah Sagin
Co-authored papers 1
Alison H Goodall
Co-authored papers 1
Olga McLeod
Co-authored papers 1
Elisabet Svenungsson
Co-authored papers 1
Roberto Vettor
University Hospital of Padova
Co-authored papers 1
Ulf de Faire
Co-authored papers 1
Karin Leander
Co-authored papers 1
Rémi Favier
Co-authored papers 1
Release 1.2